코덱시스 (CDXS) 주가

코덱시스(CDXS)는 NASDAQ에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $1.33 (+0.76%), 시가총액 $0.23B, 52주 최저~최고 $0.98 ~ $3.33.

Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.

핵심 지표

• 현재가: $1.33 (+0.76%)
• 시가총액: $0.23B
• 52주 최저~최고: $0.98 ~ $3.33
• 섹터: Healthcare
• 산업: Biotechnology
• 거래소: NASDAQ

코덱시스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

코덱시스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.2857

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 6.01
• 순이익률: -0.41%
• 영업이익률: -0.53%

자주 묻는 질문